Anne M. Phillips - May 10, 2024 Form 4 Insider Report for Barinthus Biotherapeutics plc. (BRNS)

Role
Director
Signature
/s/ William Enright, Attorney-in-Fact
Stock symbol
BRNS
Transactions as of
May 10, 2024
Transactions value $
$0
Form type
4
Date filed
5/14/2024, 04:19 PM
Previous filing
Jun 13, 2024
Next filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRNS Share Option (Right to Buy) Award $0 +19.5K $0.00 19.5K May 10, 2024 Ordinary Shares 19.5K $2.34 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.